Guidance and quality standards Awaiting development
Showing 1 to 10 of 222
| Title | Type |
|---|---|
| Abdominal aortic aneurysm | Quality standard |
| Abilify MyCite for treating bipolar disorder 1 or schizophrenia [ID3833] | Technology appraisal guidance |
| Acne | Quality standard |
| Adrenal dysfunction | Quality standard |
| Adults with lifelong or very severe hearing or visual impairment: health, well-being and social care | Quality standard |
| Advocacy services for adults with health and social care needs | Quality standard |
| Amcenestrant for treating ER-positive, HER2-negative advanced breast cancer after hormonal therapy [ID3919] | Technology appraisal guidance |
| Arimoclomol for treating Niemann-Pick disease Type C [ID1312] | Highly specialised technology |
| Asfotase alfa for treating paediatric-onset hypophosphatasia (review of HST6) [ID3927] | Highly specialised technology |
| Atezolizumab for adjuvant treatment of high-risk locally advanced squamous cell head and neck cancer [ID4052] | Technology appraisal guidance |